INSM
Closed
Insmed Inc
97.62
-3.02 (-3.00%)
Last Update: 01 Jul 2025 23:16:00
Yesterday: 100.64
Day's Range: 97.34 - 100.475
Send
sign up or login to leave a comment!
When Written:
17.29
Insmed Inc. is a biopharmaceutical company that focuses on developing therapies for patients with rare diseases. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey. Insmed's main product is ARIKAYCE, an inhaled antibiotic used to treat Mycobacterium avium complex (MAC) lung disease, a rare and serious bacterial infection that can cause severe respiratory symptoms. The company is also developing other products for rare diseases such as non-tuberculous mycobacterial (NTM) infections, primary ciliary dyskinesia (PCD), and bronchiectasis. Insmed's mission is to improve the lives of patients with rare diseases by developing innovative treatments that address unmet medical needs.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








